Respiree™ is an AI/ML health tech company building state-of-the-art clinically-validated AI for managing disease progression across healthcare’s care continuum. The iRIS platform by Respiree™ uses data from the EHR and its proprietary US-patented and FDA-cleared sensor to longitudinal measure and track disease progression. Respiree™ is now available in US and Asia-Pacific and has signed commercial tie ups with global channel partners to scale up its offerings. Respiree™ is CE marked, has received regulatory clearances in Australia from the Therapeutic Goods Administration and has received the 510(k) clearance from the United States Food and Drug Administration (FDA).